Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Omori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients&...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/8a3719f0497f496ea8119b5eec5ecf4b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8a3719f0497f496ea8119b5eec5ecf4b
record_format	dspace
spelling	oai:doaj.org-article:8a3719f0497f496ea8119b5eec5ecf4b2021-12-02T00:40:26ZOrexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]1178-2021https://doaj.org/article/8a3719f0497f496ea8119b5eec5ecf4b2018-05-01T00:00:00Zhttps://www.dovepress.com/corrigendum-orexinhypocretin-levels-in-the-cerebrospinal-fluid-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Omori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients” it should have been “Differences of the ESS scores and MSL between decreased and normal CSF orexin groups were insignificant among DM1 patients”.Read the original article Omori YKanbayashi TImanishi ATsutsui KSagawa YKikuchi YSTakeshima MYoshizawa KUemura SShimizu TDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 14, Pp 1307-1308 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Omori Y Kanbayashi T Imanishi A Tsutsui K Sagawa Y Kikuchi YS Takeshima M Yoshizawa K Uemura S Shimizu T Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
description	Omori Y, Kanbayashi T, Imanishi A, et al. Neuropsychiatr Dis Treat. 2018;14:451–457.On page 451, the Result section in the abstract, 2nd sentence reads “There were significant differences in the ESS scores and MSL between decreased and normal CSF orexin groups in DM1 patients” it should have been “Differences of the ESS scores and MSL between decreased and normal CSF orexin groups were insignificant among DM1 patients”.Read the original article
format	article
author	Omori Y Kanbayashi T Imanishi A Tsutsui K Sagawa Y Kikuchi YS Takeshima M Yoshizawa K Uemura S Shimizu T
author_facet	Omori Y Kanbayashi T Imanishi A Tsutsui K Sagawa Y Kikuchi YS Takeshima M Yoshizawa K Uemura S Shimizu T
author_sort	Omori Y
title	Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_short	Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_full	Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_fullStr	Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_full_unstemmed	Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]
title_sort	orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [corrigendum]
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/8a3719f0497f496ea8119b5eec5ecf4b
work_keys_str_mv	AT omoriy orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum AT kanbayashit orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum AT imanishia orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum AT tsutsuik orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum AT sagaway orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum AT kikuchiys orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum AT takeshimam orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum AT yoshizawak orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum AT uemuras orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum AT shimizut orexinhypocretinlevelsinthecerebrospinalfluidandcharacteristicsofpatientswithmyotonicdystrophytype1withexcessivedaytimesleepinesscorrigendum
_version_	1718403567683895296

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness [Corrigendum]

Ejemplares similares